OWC Pharmaceutical Research Corp.
CIK 0001431934
Revenue (TTM)
$100K
Q3 Nov 2019
Net Income (TTM)
$5.43M
−125.0% YoY
Q3 Nov 2019
EPS Diluted (TTM)
−$0.04
Q3 Nov 2019
Gross Margin
—
Q3 Nov 2019
Operating Margin
-4,055.7%
Q3 Nov 2019
Net Margin
5,428.0%
Q3 Nov 2019
Free Cash Flow (TTM)
−$1.42M
Q3 Nov 2019
Cash
$1.47M
Q3 Nov 2019
Total Debt
—
Q3 Nov 2019
Shares Outstanding
262.33M sh
Q3 Nov 2019
Revenue & Net Income
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.